Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Rebecca Gardner

Has grant

Associate Member

St. Jude Children's Research Hospital

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Open

Precision Evolutionary Therapies for Relapsed pediatric Acute lymphoblastic Leukemia

Open Date: 2026-01-01

Close Date: 2031-12-01

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Paibel Aguayo-HIraldo

Assistant Professor /Clinical director Transplant and Cellular Therapy

University of Southern California

UNITED STATES

View details

Zahra Mahmoudjafari

UNITED STATES

View details

Michael Keller

Assistant Professor

George Washington University

UNITED STATES

View details

Saad Kenderian

Mayo Clinic

UNITED STATES

View details

Elena Sotillo

Senior Research Scientist

Stanford University

UNITED STATES

View details

Stephan Grupp

Section Chief, Cellular Therapy and Transplant

Children's Hospital of Philadelphia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rebecca Gardner

Research Interests

Explore related searches

Recent Grants

Articles (9)

Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells

Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

Enhancing pediatric access to cell and gene therapies.

INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities

CAR T-Cells for Cure in Pediatric B-ALL

Collaborators (6)

Paibel Aguayo-HIraldo

Zahra Mahmoudjafari

Michael Keller

Saad Kenderian

Elena Sotillo

Stephan Grupp

Make your next move.